Modulation of delayed-type hypersensitivity during the time course of immune response to a protein antigen

被引:20
|
作者
Jacysyn, JF [1 ]
Abrahamsohn, IA [1 ]
Macedo, MS [1 ]
机构
[1] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil
关键词
D O I
10.1046/j.1365-2567.2001.01181.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Delayed-type hypersensitivity reactions elicited in the footpad of ovalbumin-sensitized mice after challenge with aggregated ovalbumin on day 4 or 8 of immunization are distinct. The former was characterized by a dense mononuclear infiltrate and, macroscopically. the reaction peaked at 48 hr after antigen challenge; the latter was preceded by immediate-type reactions, reached the maximum at 24 hr and faded drastically later. Histologically, oedema and a mixed granulocytic-lymphocytic infiltrate was found at this lime-point. Immunoglobulin G1 (IgG1), IgG2a acid IgE antibodies were detected only in plasma obtained after 8 days of immunization. Regarding the cytokines produced by draining lymph node cells after in vitro restimulation, interleukin-4 (IL-4) and IL-10 were predominant after 4 days and interferon-gamma and IL-2 after 8 days of immunization. These two types of delayed-type hypersensitivity (DTH) were used to study the influence of antibody-mediated responses on the inductive and effector phases of cell-mediated immunity. The effector phase of DTH was not affected by immediate-type reactions, as abrogation of these reactions by mediators antagonists on day 8 or induction of passive reactions by transfer of immune serum on day 4 did not change the extent or kinetics of either type of DTH. Only transfer, before immunization, of whole or T-cell-enriched spleen cells, but not sera, from hyperimmunized donors thigh antibody producers) abolished the induction of pure DTH in 4-day immunized recipient mice and changed their cytokine profile to a T helper 2 type. These results indicate that in a non-polarized immune response to a protein antigen there is initially a bias towards cell-mediated immunity, which is gradually dampened by the development of antibody-mediated immunity.
引用
下载
收藏
页码:373 / 379
页数:7
相关论文
共 50 条
  • [1] MODULATION OF DELAYED-TYPE HYPERSENSITIVITY TO DINITROFLUOROBENZENE BY MODULATION OF IMMUNE ASSOCIATED ANTIGEN (IA)
    HARRIS, RR
    CIPRIANO, D
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1987, 88 (04) : 494 - 494
  • [2] MODULATION OF DELAYED-TYPE HYPERSENSITIVITY TO DINITROFLUOROBENZENE BY MODULATION OF IMMUNE ASSOCIATED ANTIGEN (IA)
    HARRIS, RR
    CIPRIANO, D
    CLINICAL RESEARCH, 1987, 35 (03): : A690 - A690
  • [3] ANTIGEN RECOGNITION IN DELAYED-TYPE HYPERSENSITIVITY
    FLEISCHMAN, JB
    EISEN, HN
    CELLULAR IMMUNOLOGY, 1975, 15 (02) : 312 - 320
  • [4] DELAYED-TYPE HYPERSENSITIVITY AND AIDS - RESPONSE
    BLATT, SP
    HENDRIX, CW
    ANNALS OF INTERNAL MEDICINE, 1994, 120 (04) : 344 - 344
  • [5] Pharmacologic modulation of delayed-type hypersensitivity in mice
    Yamada, N
    Sugasawa, K
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1996, 46 (09): : 884 - 886
  • [6] Unique protein signatures evolve during the course of a delayed-type hypersensitivity reaction in human skin
    Han, Joseph
    Stratman, Scott
    Young, Jade N.
    Poplausky, Dina
    Owji, Shayan
    Luu, Yen
    Estrada, Yeriel
    da Rosa, Joel Correa
    Krueger, James G.
    Gulati, Nicholas
    JOURNAL OF DERMATOLOGY, 2023, 50 (06): : 804 - 809
  • [7] MODULATION OF DELAYED-TYPE HYPERSENSITIVITY BY HISTAMINE IN MICE
    TOMINAGA, K
    SATOH, K
    NAKAMURA, J
    MOTOKI, T
    TSUBURA, E
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1980, 2 (03): : 234 - 234
  • [8] THE REGULATION OF DELAYED-TYPE HYPERSENSITIVITY RESPONSES IS INFLUENCED BY THE ANTIGEN
    CLARK, C
    DALMASSO, AP
    FEDERATION PROCEEDINGS, 1981, 40 (03) : 1096 - 1096
  • [9] INTERFERON AND DELAYED-TYPE HYPERSENSITIVITY TO A VIRAL-ANTIGEN
    DEMAEYER, E
    JOURNAL OF INFECTIOUS DISEASES, 1976, 133 : A63 - A65
  • [10] SUPPRESSION OF DELAYED-TYPE HYPERSENSITIVITY BY ORAL ANTIGEN ADMINISTRATION
    KAGNOFF, MF
    CLINICAL RESEARCH, 1977, 25 (03): : A313 - A313